Wave Life Sciences Ltd
General ticker "WVE" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $1.9B
Wave Life Sciences Ltd follows the US Stock Market performance with the rate: 51.0%.
Estimated limits based on current volatility of 3.8%: low 12.82$, high 13.82$
Factors to consider:
- Current price 82.5% above estimated high
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [3.35$, 7.19$]
- 2024-12-30 to 2025-12-30 estimated range: [3.22$, 7.06$]
Financial Metrics affecting the WVE estimates:
- Negative: Non-GAAP EPS, $ of -0.55 <= 0.10
- Negative: Operating profit margin, % of -37.50 <= 1.03
- Negative: Operating cash flow per share per price, % of -3.50 <= 2.35
- Negative: negative Net income
- Positive: Interest expense per share, $ of 0 <= 0
Short-term WVE quotes
Long-term WVE plot with estimates
Financial data
YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|
Operating Revenue | $40.96MM | $3.65MM | $113.31MM |
Operating Expenses | $167.98MM | $166.37MM | $181.30MM |
Operating Income | $-127.02MM | $-162.72MM | $-68.00MM |
Non-Operating Income | $4.57MM | $1.58MM | $9.81MM |
R&D Expense | $121.88MM | $115.86MM | $130.01MM |
Income(Loss) | $-122.45MM | $-161.14MM | $-58.19MM |
Taxes | $-0.20MM | $0.68MM | $-0.68MM |
Profit(Loss) | $-122.25MM | $-161.82MM | $-57.51MM |
Stockholders Equity | $32.50MM | $-45.09MM | $39.63MM |
Assets | $207.01MM | $146.39MM | $274.95MM |
Operating Cash Flow | $-88.99MM | $-127.78MM | $-19.43MM |
Capital expenditure | $0.56MM | $1.36MM | $1.11MM |
Investing Cash Flow | $-0.56MM | $-1.25MM | $-1.11MM |
Financing Cash Flow | $55.83MM | $67.19MM | $132.53MM |
Earnings Per Share* | $-2.36 | $-2.05 | $-0.54 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.